Adeno-Associated Viral Vector Manufacturing: Keeping Pace with Accelerating Clinical Development

Abstract

Get full access to this article

View all access options for this article.

References

Mingozzi

, High

K.A.

2011. Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat. Rev. Genet., 12:341–355.

Urabe

, Ding

, Kotin

R.M.

2002. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther., 13:1935–1943.

Wasilko

D.J.

, Lee

S.E.

, Stutzman-Engwall

K.J.

et al. 2009. The titerless infected-cells preservation and scale-up (TIPS) method for large-scale production of NO-sensitive human soluble guanylate cyclase (sGC) from insect cells infected with recombinant baculovirus. Protein Expr. Purif., 65:122–132.